×
About 7,618 results

ALLMedicine™ Myocarditis Center

Research & Reviews  2,598 results

Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry
https://clinicaltrials.gov/ct2/show/NCT05158751

Jan 14th, 2022 - Hypothesized that occult inflammation is clinically under-recognized in patients with symptomatic PVCs with and without Left ventricular (LV) dysfunction and can be a potential link between the 2 conditions. Aimed to evaluate the incidence of unde...

Self-limiting COVID-19-associated Kikuchi-Fujimoto disease with heart involvement: case...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757403
Rheumatology International; Masiak A, Lass A et. al.

Jan 14th, 2022 - The association between COVID-19 infection and the development of autoimmune diseases is currently unknown, but there are already reports presenting induction of different autoantibodies by SARS-CoV-2 infection. Kikuchi-Fuimoto disease (KFD) as a ...

SARS-CoV-2-Associated Myocarditis: A Case of Direct Myocardial Injury.
https://doi.org/10.1161/CIRCHEARTFAILURE.120.008273
Circulation. Heart Failure; Verma AK, Olagoke O et. al.

Jan 12th, 2022 - SARS-CoV-2-Associated Myocarditis: A Case of Direct Myocardial Injury.|2022|Verma AK,Olagoke O,Moreno JD,Rezaee N,Ma P,|

Safety and effectiveness of BNT162b2 mRNA Covid-19 vaccine in adolescents.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702409
Vaccine June Choe Y, Yi S et. al.

Jan 12th, 2022 - In South Korea, all 12th grade students (highs school seniors) were offered BNT162b2 vaccine starting July 19, 2021; while 10th-11th grade students were not eligible. We conducted a nationwide retrospective cohort study by to determine the safety ...

see more →

Guidelines  7 results

Screening of Potential Cardiac Involvement in Competitive Athletes Recovering From COVI...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598679
JACC. Cardiovascular Imaging; Phelan D, Kim JH et. al.

Dec 12th, 2020 - As our understanding of the complications of coronavirus disease-2019 (COVID-19) evolve, subclinical cardiac pathology such as myocarditis, pericarditis, and right ventricular dysfunction in the absence of significant clinical symptoms represents ...

Management of Acute Myocardial Infarction During the COVID-19 Pandemic: A Position Stat...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7173829
Journal of the American College of Cardiology; Mahmud E, Dauerman HL et. al.

Apr 25th, 2020 - The worldwide pandemic caused by the novel acute respiratory syndrome coronavirus 2 has resulted in a new and lethal disease termed coronavirus disease-2019 (COVID-19). Although there is an association between cardiovascular disease and COVID-19, ...

Surgical Infection Society Guidance for Operative and Peri-Operative Care of Adult Pati...
https://doi.org/10.1089/sur.2020.101
Surgical Infections; Heffernan DS, Evans HL et. al.

Apr 21st, 2020 - Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)-associated viral infection (coronavirus disease 2019, COVID-19) is a virulent, contagious viral pandemic that is affecting populations worldwide. As with any airborne viral r...

Pediatric Cardiac Intensive Care Society 2014 Consensus Statement: Pharmacotherapies in...
https://doi.org/10.1097/PCC.0000000000000626
Pediatric Critical Care Medicine : a Journal of the Socie... Singh RK, Humlicek T et. al.

Mar 6th, 2016 - In this Consensus Statement, we review the etiology and pathophysiology of inflammatory processes seen in critically ill children with cardiac disease. Immunomodulatory therapies aimed at improving outcomes in patients with myocarditis, heart fail...

Parvovirus B19 infection in pregnancy.
https://doi.org/10.1016/S1701-2163(15)30390-X
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Crane J, Mundle W et. al.

Feb 11th, 2015 - This guideline reviews the evidence relating to the effects of parvovirus B19 on the pregnant woman and fetus, and discusses the management of women who are exposed to, who are at risk of developing, or who develop parvovirus B19 infection in preg...

see more →

Drugs  33 results see all →

Clinicaltrials.gov  60 results

Myocarditis Causing Premature Ventricular Contractions:Insights From the MAVERIC Registry
https://clinicaltrials.gov/ct2/show/NCT05158751

Jan 14th, 2022 - Hypothesized that occult inflammation is clinically under-recognized in patients with symptomatic PVCs with and without Left ventricular (LV) dysfunction and can be a potential link between the 2 conditions. Aimed to evaluate the incidence of unde...

Clinical Significance of Subclinical Myocardial Involvement in Recovered COVID-19 Patients Using Cardiovascular Magnetic Resonance
https://clinicaltrials.gov/ct2/show/NCT05184114

Jan 11th, 2022 - COVID-19 Cardiovascular Complications: So far, COVID-19 has been linked to myocarditis, myocardial infarction, thrombosis/ hypercoaguable state and reduced cardiac function. At an early stage of the COVID-19 pandemic, it became apparent that cardi...

Post Coronavirus Disease (COVID-19) Syndrome Indonesian Population
https://clinicaltrials.gov/ct2/show/NCT05060562

Dec 2nd, 2021 - Target Population: As explained in the study population section Recruitment Snowball technique from the COVID 19 survivor groups Online questionnaire is provided to obtain the data Data Source: Medical Resume Laboratory Information possessed by in...

The ORCHESTRATE-Myocarditis Registry
https://clinicaltrials.gov/ct2/show/NCT05139329

Dec 1st, 2021 - Multicenter, retrospective, observational study consisting of patients who presents with typical/atypical chest pain to the emergency department and have an ensuing negative ischemic evaluation. Planned to review the subsequent diagnostic process ...

Presentation, Patterns of Myocardial Damage, and Clinical Course of Viral Myocarditis
https://clinicaltrials.gov/ct2/show/NCT04312490

Nov 23rd, 2021 - Objectives There are almost no data regarding the relative prevalence of viral pathogens associated with myocarditis and the demographic and clinical features related to these infections in Egypt. Therefore, our main interest is to determine the p...

see more →

News  335 results

COVID-Vaccine Myocarditis: Rare, Mild, and Usually a Guy Thing
https://www.medscape.com/viewarticle/966244

Jan 7th, 2022 - The risk of myocarditis after immunization with mRNA-based vaccines against SARS-CoV-2 raised concerns when it came to light in early 2021. But as report after report showed such cases to be rare and usually mild and self-limited, focus has turned...

Severe Breakthrough Infections; New Type of CAR-T Therapy; Global Cancer Toll Rises
https://www.medpagetoday.com/hematologyoncology/othercancers/96537

Jan 6th, 2022 - A study of fully vaccinated patients with cancer showed that breakthrough COVID infections were often severe, requiring hospitalization in two-thirds of cases. (Annals of Oncology) A hockey fan has a $10,000 start on funding medical school after s...

Israel Reports Very Few Myocarditis Cases Among 12- to 15-Year-Olds After Booster
https://www.medscape.com/viewarticle/966071

Jan 6th, 2022 - JERUSALEM (Reuters) - Only two cases of myocarditis were reported in Israel among 44,000 youngsters aged 12 to 15 who received a third dose of the Pfizer/BioNtech vaccine, the Health Ministry said on Wednesday. The heart inflammations developed by...

CDC Panel Pushes Boosters for All Teens
https://www.medpagetoday.com/infectiousdisease/covid19vaccine/96525

Jan 5th, 2022 - Adolescents ages 12-17 should receive a booster dose of Pfizer's COVID-19 vaccine (Comirnaty), the CDC's Advisory Committee on Immunization Practices (ACIP) said on Wednesday. ACIP voted 13-1 to recommend a booster dose of Pfizer vaccine at least ...

FDA Backs Pfizer Booster for 12- to 15-Year-Olds
https://www.medscape.com/viewarticle/965903

Jan 3rd, 2022 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. The FDA on Monday authorized the first COVID-19 vaccine booster dose for American adolescents ages 12 to 15. Besides updating the authorization fo...

see more →

Patient Education  14 results see all →